HomeTENX • NASDAQ
Tenax Therapeutics Inc
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.34M | 190.10% |
Net income | -10.41M | -173.98% |
Net profit margin | — | — |
Earnings per share | -0.28 | 91.03% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 111.45M | 788.06% |
Total assets | 112.06M | 674.94% |
Total liabilities | 2.77M | 36.32% |
Total equity | 109.29M | — |
Shares outstanding | 4.15M | — |
Price to book | 0.23 | — |
Return on assets | -27.16% | — |
Return on capital | -28.16% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.41M | -173.98% |
Cash from operations | -6.97M | -34.87% |
Cash from investing | — | — |
Cash from financing | 23.56M | 197.40% |
Net change in cash | 16.60M | 501.88% |
Free cash flow | -7.79M | -104.13% |
Previous close
$6.22
Day range
$6.00 - $6.25
Year range
$2.77 - $7.89
Market cap
25.09M USD
Avg Volume
12.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1967
Website
Employees
5
